These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 7430884)

  • 1. Effect of bromocriptine, ergotamine and other ergot alkaloids on the hormone secretion and growth of a rat pituitary tumour.
    Prysor-Jones RA; Jenkins JS
    J Endocrinol; 1980 Jul; 86(1):147-53. PubMed ID: 7430884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of bromocriptine on DNA synthesis, growth and hormone secretion of spontaneous pituitary tumours in the rat.
    Prysor-Jones RA; Jenkins JS
    J Endocrinol; 1981 Mar; 88(3):463-9. PubMed ID: 7217831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of tamoxifen on growth and prolactin secretion of rat pituitary tumours.
    Prysor-Jones RA; Silverlight JJ; Jenkins JS
    J Endocrinol; 1983 May; 97(2):261-6. PubMed ID: 6854193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ergot alkaloids on growth hormone and prolactin secretion in humans.
    Silvestrini F; Liuzzi A; Chiodini PG
    Pharmacology; 1978; 16 Suppl 1():78-87. PubMed ID: 643905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of extracellular matrix on secretion of prolactin and growth hormone by rat pituitary tumour cells in vitro.
    Prysor-Jones RA; Silverlight JJ; Jenkins JS
    Acta Endocrinol (Copenh); 1985 Feb; 108(2):156-60. PubMed ID: 3918400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of bromocriptine, somatostatin, and oestradiol-17 beta on hormone secretion and ultrastructure of human pituitary tumours in vitro.
    Prysor-Jones RA; Kennedy SJ; O'Sullivan JP; Jenkins JS
    Acta Endocrinol (Copenh); 1981 Sep; 98(1):14-23. PubMed ID: 6116372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of bromocriptine on hormone production and cell growth in cultured rat pituitary cells.
    Johansen PW; Haug E; Gautvik KM
    Acta Endocrinol (Copenh); 1985 Oct; 110(2):200-6. PubMed ID: 4060970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA synthesis by pituitary tumours, with reference to plasma hormone levels and to effects of bromocriptine.
    Lloyd HM; Jacobi JM; Willgoss DA
    Clin Endocrinol (Oxf); 1995 Jul; 43(1):79-85. PubMed ID: 7641414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive mixed growth hormone/prolactin secreting pituitary tumour: complete shrinking by octreotide and bromocriptine, and lack of tumour growth relapse 20 months after octreotide withdrawal.
    Sadoul JL; Thyss A; Freychet P
    Acta Endocrinol (Copenh); 1992 Feb; 126(2):179-83. PubMed ID: 1543025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of the somatostatin analog SMS 201-995 on normal growth hormone secretion in the rat. A comparison with the effect of bromocriptine on normal prolactin secretion.
    Lamberts SW; Verleun T; Zuiderwijk JM; Oosterom R
    Acta Endocrinol (Copenh); 1987 Jun; 115(2):196-202. PubMed ID: 2885995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen suppresses both the growth of prolactin-secreting pituitary tumours and normal prolactin synthesis in the rat.
    de Quijada M; Timmermans HA; Lamberts SW
    J Endocrinol; 1980 Jul; 86(1):109-16. PubMed ID: 7430882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of prolactin in the inhibitory action of bromocriptine on growth hormone secretion in acromegaly.
    Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ; Liuzzi A
    Acta Endocrinol (Copenh); 1983 Aug; 103(4):446-50. PubMed ID: 6310918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison between the effects of SMS 201-995, bromocriptine and a combination of both drugs on hormone release by the cultured pituitary tumour cells of acromegalic patients.
    Lamberts SW; Verleun T; Hofland L; Del Pozo E
    Clin Endocrinol (Oxf); 1987 Jul; 27(1):11-23. PubMed ID: 2888550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of pituitary tumor growth and function by ergot alkaloids.
    MacLeod RM; Lehmeyer JE
    Cancer Res; 1973 Apr; 33(4):849-55. PubMed ID: 4348776
    [No Abstract]   [Full Text] [Related]  

  • 15. Dopaminergic regulation of prolactin and growth hormone synthesis in rat pituitary tumor cells.
    Cheung CY; Melmed S; Braunstein GD
    Brain Res; 1983 Jun; 270(1):165-8. PubMed ID: 6871710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytocidal effects of bromocriptine, somatostatin analog, and heat on growth hormone-secreting pituitary adenoma in vitro.
    Kawamoto K; Uozumi T; Sakoda K; Mukada K; Kurisu K; Yano T
    Cancer; 1992 Jun; 69(11):2688-96. PubMed ID: 1571899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the effects of four ergot derivatives on prolactin secretion by dispersed rat pituitary cells.
    Delitala G; Yeo T; Grossman A; Hathway NR; Besser GM
    J Endocrinol; 1980 Oct; 87(1):95-103. PubMed ID: 7430919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ergot-induced inhibition of pituitary tumor growth in rats.
    Quadri SK; Lu KH; Meites J
    Science; 1972 Apr; 176(4033):417-8. PubMed ID: 5026161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphological changes in bromocriptine-treated pituitary tumours.
    Anniko M; Wersäll J
    Acta Otolaryngol; 1983; 96(3-4):337-53. PubMed ID: 6637451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of ergot alkaloids in clinical use.
    Berde B
    Med J Aust; 1978 Nov; 2(3 Suppl):3-13. PubMed ID: 370528
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.